STEGLATRO is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Ertugliflozin Pidolate.
| Product ID | 50090-6182_62ebce91-1a76-4c3b-bc52-4953699e116c | 
| NDC | 50090-6182 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | STEGLATRO | 
| Generic Name | Ertugliflozin | 
| Dosage Form | Tablet, Film Coated | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2017-12-19 | 
| Marketing Category | NDA / | 
| Application Number | NDA209803 | 
| Labeler Name | A-S Medication Solutions | 
| Substance Name | ERTUGLIFLOZIN PIDOLATE | 
| Active Ingredient Strength | 5 mg/1 | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2023-12-31 | 
| Marketing Start Date | 2022-10-20 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0006-5363 | STEGLATRO | ertugliflozin | 
| 0006-5364 | STEGLATRO | ertugliflozin | 
| 50090-6182 | STEGLATRO | ertugliflozin | 
| 50090-6183 | STEGLATRO | ertugliflozin | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  STEGLATRO  86576333  5498114 Live/Registered | Merck Sharp & Dohme Corp. 2015-03-25 |